Seres Therapeutics Files Prospectus Related to Resale,From Time to Time, of up to 14.3 Mln Shares of Common Stock by Selling Stockholder- SEC Filing
seres therapeutics提交拟议书,涉及证券交易委员会文件中不时地由卖方股东转售的多达14.3百万股普通股。
Seres Therapeutics Files Prospectus Related to Resale,From Time to Time, of up to 14.3 Mln Shares of Common Stock by Selling Stockholder- SEC Filing
seres therapeutics提交拟议书,涉及证券交易委员会文件中不时地由卖方股东转售的多达14.3百万股普通股。
使用浏览器的分享功能,分享给你的好友吧